CONVERGENT THERAPEUTICS

Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy developed by Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. CONV 01-ฮฑ, a monoclonal antibody conjugated with 225Ac, a radioactive alpha particle emitter, was specifical... ly designed to bind to the prostate-specific membrane antigen (PSMA). A key functional feature of CONV 01-ฮฑ is that, once bound to PSMA, it becomes internalized, thereby delivering its powerful radioactive payload directly into the prostate cancer cells. CONV 01-ฮฑ is covered by multiple issued U.S. and foreign patents. If FDA-approved, CONV 01-ฮฑ would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment.

#SimilarOrganizations #People #More

CONVERGENT THERAPEUTICS

Status:
Active


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

Current Employees Featured

philip-kantoff_image

Philip Kantoff
Philip Kantoff Co-Founder & CEO @ Convergent Therapeutics
Co-Founder & CEO
2021-07-01

alexander-brown_image

Alexander Brown
Alexander Brown COO @ Convergent Therapeutics
COO
2021-07-01

Founder


philip-kantoff_image

Philip Kantoff

More informations about "Convergent Therapeutics"

Learn About Convergent Therapeutics

World-renowned medical oncologist and scientist. Prior to joining Convergent Therapeutics, Dr. Kantoff spent six years as Chairman of the Department of Medicine at Memorial Sloan โ€ฆSee details»

Convergent Therapeutics - Crunchbase Company โ€ฆ

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer. The company's proprietary technology involves dual-targeted radionuclide therapy developed โ€ฆSee details»

Convergent Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap

Convergent Therapeutics has received its first shipment of the radioisotope actinium-225 from Cardinal Health to make its Phase 1/2 prostate cancer radiopharmaceutical, according to a โ€ฆSee details»

Convergent Therapeutics, Inc. - The Org

Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic โ€ฆSee details»

Convergent Therapeutics, Inc. | LinkedIn

Convergent Therapeutics, Inc. | 2,377 followers on LinkedIn. Developing next-generation targeted combination therapies to advance the care of cancer patients. | Convergent Therapeutics is a ...See details»

NorthStar Medical Radioisotopes and Convergent Therapeutics, โ€ฆ

Aug 13, 2024 About Convergent Therapeutics, Inc. Convergent Therapeutics Inc. is a clinical-stage biotechnology company focused on developing tumor-selective alpha radioantibodies to โ€ฆSee details»

Convergent circles up $90M for cancer โ€ฆ

May 3, 2023 Convergent Therapeutics has circled up $90 million to develop next-gen radiopharmaceuticals in oncology, with its lead clinical program targeting prostate cancer. | Convergent Therapeutics has ...See details»

Convergent Therapeutics gets $90M for radiopharmaceuticals

May 5, 2023 Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, today โ€ฆSee details»

Convergent Therapeutics, Inc. - Center For Technology Licensing

Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers. The companyโ€™s โ€ฆSee details»

Convergent Therapeutics Announces First Patient Treated in

Sep 24, 2024 Convergent Therapeutics Inc. is a clinical-stage biotechnology company focused on developing tumor-selective alpha radioantibodies to target cancer. The company was โ€ฆSee details»

Convergent Therapeutics - Funding, Financials, Valuation & Investors

May 3, 2023 Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer. Search Crunchbase. Start Free Trial . ...See details»

Convergent Therapeutics Announces $90 Million Series A โ€ฆ

May 3, 2023 Convergent Therapeutics Inc. is a clinical-stage biotechnology company focused on developing next-generation radiopharmaceutical therapies for prostate and other cancers.See details»

Convergent Therapeutics - VentureRadar

Convergent Therapeutics is a clinical-stage biotechnology company developing targeted radiopharmaceuticals to treat cancer. Radioantibodies precisely target and kill cancer cells โ€ฆSee details»

Convergent Therapeutics - Updates, News, Events, Signals

Dec 11, 2024 PR Newswire โ€” Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial Funding โ€ฆSee details»

Convergent Therapeutics Announces First Patient Treated in Phase โ€ฆ

CAMBRIDGE, Mass., Sept. 24, 2024 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical โ€ฆSee details»

Convergent Therapeutics - PitchBook

When was Convergent Therapeutics founded? Convergent Therapeutics was founded in 2020. Where is Convergent Therapeutics headquartered? Convergent Therapeutics is โ€ฆSee details»

Convergent Therapeutics Announces First Patient Treated in Phase โ€ฆ

Sep 24, 2024 About Convergent Therapeutics, Inc. Convergent Therapeutics Inc. is a clinical-stage biotechnology company focused on developing tumor-selective alpha radioantibodies to โ€ฆSee details»

Convergent Therapeutics - Craft

Convergent Therapeutics is a biotechnology company that develops radiotherapies for cancer treatment. It offers CONV 01-ฮฑ, a monoclonal antibody conjugated with a radioactive alpha โ€ฆSee details»

Convergent Therapeutics - Contacts, Employees, Board Members, โ€ฆ

Organization. Convergent Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of โ€ฆSee details»

Computational frameworks transform antagonism to synergy in โ€ฆ

1 day ago Basic concepts and role of AI in drug combination prediction. In combination drug therapy, synergy and antagonism are two fundamental concepts that describe the interactions โ€ฆSee details»

linkstock.net © 2022. All rights reserved